Where does Asahi Kasei Pharma Corporation rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Asahi Kasei Pharma Corporation ranks #12,357 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Asahi Kasei Pharma Corporation hold?

Asahi Kasei Pharma Corporation holds 24 US utility patents granted between 2015 and 2025, spanning 13 technology areas.

What is Asahi Kasei Pharma Corporation's Innovation Score?

Asahi Kasei Pharma Corporation has an Innovation Score of 38.5 out of 100 (top 40% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Asahi Kasei Pharma Corporation focus on?

Asahi Kasei Pharma Corporation's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 18 patents, ranking #1,084 of 6,058 assignees active in that subclass. Grants appear in 13 CPC subclasses total.

Is Asahi Kasei Pharma Corporation's patent grant rate increasing or decreasing?

Asahi Kasei Pharma Corporation's recent grant velocity is +9% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Asahi Kasei Pharma Corporation's patents?

Asahi Kasei Pharma Corporation's patents average 17.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Asahi Kasei Pharma Corporation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Asahi Kasei Pharma Corporation

USPTO PatentsView assignee record - 24 granted patents across 13 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Asahi ranks #12,357 of 49,997 tracked US assignees by granted-patent volume, with 24 patents across 13 technology areas.

#12,357
of 49,997 US assignees by volume: Top 40%
by Innovation Score (38.5/100): 17.5
avg claims per patent: +9%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R12357 · Foreign Corporation #12,357 · 24 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL

GRANTS-SMALL 24 grants
UPPER-Q #12,357/49,997
PHOTO-FINISH Arçelik Anonim Sirketi
CPC-FOCUS A61P · 13 areas
INNOV-THIN 38.5/100
CLAIMS-RICH 17.5 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-FLAT +9% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Arçelik Anonim Sirketi (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Asahi’s 38.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.1 pts (29%) Velocity 4.2 pts (11%) Breadth 12.7 pts (33%) Claim depth 10.5 pts (27%)

Qualcomm Incorporated · highest

85
Asahi Kasei Pharma · this assignee

39
3D Lighting… · lowest

7

What this shows Asahi's Innovation Score is 38.5/100 (top 40% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Asahi?

Each dot is one of Asahi’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Asahi’s own 17.5 claims/patent is ABOVE the 15.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Asahi vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Asahi's grants concentrate

Asahi Kasei Pharma Corporation is a focused PatentsView assignee: 13 CPC subclasses with 75% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2015 (4 grants) versus a trough of 1 in 2016. By volume, Asahi sits between Archem Inc. and Babylon Partners Limited.

Asahi's three-year grant acceleration

Asahi Kasei Pharma Corporation shows 5 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Archem

24
Archroma IP

24
Arkade

24
Arçelik Anonim Si…

24
Astera Labs

24
Astura Medical

24
Avantama

24
Babylon Partners

24
Asahi Kasei Pharma ◀

24

What this shows Asahi holds 24 patents at rank #12,360, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Asahi

By rank, the assignees closest to #12,360 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Asahi's primary technology class.

Asahi's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 40% higher than 60% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Asahi Kasei Pharma Corporation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	4	16.7%
2016	1	4.2%
2017	3	12.5%
2018	2	8.3%
2019	1	4.2%
2020	3	12.5%
2021	4	16.7%
2022	2	8.3%
2023	2	8.3%
2024	1	4.2%
2025partial year	1	4.2%

Which technologies does Asahi Kasei Pharma Corporation patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 18

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 17

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 9

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 7

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 6

C07K - Peptides 5

C07D - Heterocyclic Compounds 5

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 3

C12Y - Enzymes 3

B65B - Machines, Apparatus OR Devices FOR, OR Methods OF, Packaging Articles OR MATERIALS; Unpacking 2

C12R - Indexing Scheme Associated With Subclasses C12c - C12q, Relating TO Microorganisms 2

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 1

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 1

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Asahi Kasei Pharma Corporation's patent record in context - here's where to go next.

Asahi Kasei Pharma Corporation's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 75% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #12,357 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Asahi Kasei Pharma Corporation against Archem Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 38.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.